(IMTK) Imaginatik
Summary
Trade long or short on this share now through an Interactive Investor Spread Bet or CFD
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 07:00 | RNS |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 9954W Imaginatik PLC 08 February 2012 8 February 2012
Imaginatik Plc ("Imaginatik" or "the Company") Issue of Equity
Imaginatik plc (AIM:IMTK), a leading provider of enterprise innovation services including a range of technology products and consultancy, is pleased to announce that following demand from certain existing and new investors, 85,505,352 new ordinary shares of 0.0625p each in the Company ("Subscription Shares") have been subscribed for at a price per share of 0.3 pence (the "Subscription Price"), to raise £256,516 before expenses. The Company intends that the net proceeds of the issue will be used for working capital purposes.
Application has been made for the new Shares to be admitted to trading on AIM, and dealings in the Subscription Shares are expected to commence at 8.00 a.m. on 13 February 2012 ("Admission"), following which the Company will have 513,032,110 Ordinary Shares in issue. This figure may be used by shareholders, from Admission, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
The Directors named below have subscribed for Subscription Shares as set out below at the Subscription Price:
Each Directors' interests in Ordinary Shares in the Company is accordingly as follows:
The interests of Mr Gammon set out above in ordinary shares include those of his wife, Sarah Gammon.
The aggregate subscription by the Directors (the "Directors' Participations") constitutes a related party transaction for the purposes of the AIM Rules. Luis Solis, the Director who is deemed to be independent for the purposes of this participation in the subscription, considers, having consulted with Northland Capital Partners Limited as the Company's nominated adviser, that the terms of the Directors' Participations are fair and reasonable insofar as Shareholders are concerned. Executive Chairman of Imaginatik, Matt Cooper, commented, "We have taken significant strides forward in recent months, strengthening our team, investing in our technology products and services and securing some of the world's largest businesses as customers. We are delighted that this progress has resulted in increased interest from employees and investors to fund the Company. Imaginatik is in a strong position, with a good sales pipeline and a motivated team and we continue to be focused on delivering the positive results our shareholders deserve." For further information please contact:
About Imaginatik
Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.
Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fri 11:39 | RNS |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 7676W Imaginatik PLC 03 February 2012
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thu 10:49 | RNS |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 6827W Imaginatik PLC 02 February 2012
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30-01-12 | RNS |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 3493W Imaginatik PLC 30 January 2012 30 January 2012 Imaginatik plc ("Imaginatik" or the "Company")
Senior Management Appointments
Imaginatik plc (AIM: IMTK), a leading provider of enterprise innovation services including a range of technology products and consultancy, is pleased to announce the appointment of two senior executives to the management team, adding to the Company's sales and consultancy expertise. Elisa O'Donnell has been appointed Head of Consultancy and Jonathan Jewett as Head of Sales. Neither of the appointments are Board appointments.
Elisa O'Donnell has over 20 years of management consulting experience in the field of innovation and change. In her role as Head of Consultancy, Elisa will be responsible for running the Company's consulting practice based in Boston. Elisa's previous positions include being part of the leadership teams at Continuum, a design thinking consultancy, Synecticsworld, an innovation consultancy, and other leadership positions at A.T. Kearney and Coopers and Lybrand (PWC). Some of Elisa's clients have included Fidelity Investments, L'Oreal, American Express, Blue Cross Blue Shield and Merck Pharmaceuticals. She has also led research and development efforts on new organisational innovation approaches, and has spoken and been published on managing innovation and change.
Jonathan Jewett is an experienced sales director with a successful track record of building and motivating high-performance sales teams within the technology industry. At Imaginatik he will be responsible for global sales, based in Boston. He joins Imaginatik from NYSE listed PGi, the global provider of collaborative conferencing services, where he was part of the Global Business Development team since 2010. Prior roles include Senior Sales Manager at Accept Software, an innovation management and social media company, Director of US Sales at Resolve Technology, a business intelligence company, Director of North American Sales at SolidWorks Corporation, a $200m revenue CAD software company, and Regional Sales Manager at Oracle.
Matt Cooper, Executive Chairman of Imaginatik, commented, "The appointments of Jonathan and Elisa will add considerable expertise and depth to our management team in the areas of sales and consultancy. We believe we now have the correct structure in place to take Imaginatik forward as a full service innovation solutions company offering both award-winning software and leading consultancy capabilities. We are excited about the future and look forward to delivering both excellent results for our customers and increased shareholder value."
For further information please contact:
About Imaginatik
Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.
Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Result Pages: 1 | ||||
| Date/Time | Subject | Author | ||
|---|---|---|---|---|
| 16-05-11 | ||||
|
|
||||
|
|
||||
|
Imaginatik has one law suit - available in the public domain. There is a second one involving the company that may have been listed in the Daily Star recap of the top 50 super-injunctions - that would be a great irony. Hundreds of thousands of pounds of shareholders money - precious given the precarious financial situation of the firm - given to lawyers for... what? Can't tell. Now, I have left the United Kingdom as a resident so we shall see what happens next.
Fingers crossed that something can be salvaged if you are a poor shareholder who bought into the vision, and got left in today's fog. I can genuinely and completely say - not my fault. Look at the performance of the company and its stock - present management to past. Share price dropped from a high of 9p when present Executive Chairman joined, to a steadfast 1.5p. Congratulations!! Yeah! Go Octopus Investments for giving Imaginatik its chairman. Nice move - and I hope your own investors are happy with the outcome. |
||||
| 16-05-11 | ||||
|
|
||||
|
|
||||
|
http://www.telegraph.co.uk/finance/yourbusiness/8516037/Spigit-stop-moaning-and-buy-the-best.html
The company also confirmed that there are no analyst reports available for the company, no forecasts, and they believe that the cryptic note on trading in March is sufficient disclosure to the market. |
||||
| 28-04-11 | ||||
|
|
||||
|
|
||||
|
Does anyone have a market forecast for the company for the year finished in March 2011, and for the upcoming year. The coded RNS with a statement that the revenue will be lower, and that there will be a loss for the second half are undecipherable.
|
||||
| 15-04-11 |
2 |
|||
|
|
||||
|
|
||||
|
Newspaper Briefing, Including Crisis not over without jobs recovery - IMF Chief
7:13 am The Times *Tiddler to Watch:* The World Bank is good customer to have on your books, if Imaginatiks share price is any yardstick. The small-cap software and consultancy company, which sells innovation and idea management solutions, rose 27% to 1.75p, on the back of a new licence deal with the Bank, which will boost revenue to $4 million (£2.5 million) this year. http://www.proactiveinvestors.co.uk/columns/guardian-cfd-s-newspaper-briefing/5097/newspaper-briefing-including-crisis-not-over-without-jobs-recovery-imf-chief-5097.html |
||||
|
|
||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
Glenstrata's just a silly word. Stick to big dividendsEditor's Pick:
Bulls should head for ChinaEditor's Pick:
Stock to Watch: Imperial TobaccoEditor's Pick:
George Godber’s AIM stock picks

